K

M

M Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

14

Common Fundraising Type

Series A

M
MemryX

Semiconductor • Edge AI

Motus Ventures logo
M Ventures logo
HarbourVest logo
eLab Ventures logo

MemryX develops edge AI processing solutions using proprietary compute-at-memory technology and dataflow architecture for industries like transportation, IoT, and industrial applications.

Series B
$44M
03/27/2025
Article
T
TRIMTECH Therapeutics

Biotech • Targeted protein degradation

SV Health Investors logo
Cambridge Innovation Capital logo
Pfizer Ventures logo
MP Healthcare Venture Management logo

TRIMTECH Therapeutics is a biotech company developing targeted protein degradation therapeutics for neurodegenerative diseases using TRIMTAC degrader molecules.

Seed
$32M
03/05/2025
Article
N
NovoLINC

Thermal technology • Nanostructured materials

TDK Ventures logo
M Ventures logo
Foothill Ventures logo

NovoLINC develops advanced thermal interface solutions using nanostructured materials to improve heat management in high-performance computing and semiconductor industries.

Seed
Undisclosed
01/21/2025
Article
S
Siren

Diabetic foot ulcer • Prevention

Manta Ray Ventures logo
M logo
Founders Fund logo
DCM logo

Siren develops sensor-embedded socks designed to prevent diabetic foot ulcers by detecting foot temperature changes.

Equity
$9.5M
01/08/2025
Article
A
Abselion

Automated • Analytical

Untitled Ventures logo
R42 logo
M Ventures logo
BioProcess 360 Partners logo

Abselion develops automated analytical instruments for at-line protein quantification in biopharmaceutical research and production.

Series A
$8.4M
12/09/2024
Article
I
IonKraft

Plasma-based coating • Recyclable packaging

TechVision Fund logo
M Ventures logo
High-Tech-Grunderfonds logo

IonKraft develops plasma-based coating machines to make plastic packaging recyclable and free of PFAS.

Equity
$3.7M
11/18/2024
Article
K
Kivu Bioscience

Biotech • Antibody-drug conjugates

Novo Holdings logo
Red Tree Venture Capital logo
M Ventures logo
HealthCap logo

Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates for cancer treatment.

Series A
$92M
10/28/2024
Article
N
NanoSyrinx

Synthetic biotech • Nano syringe

BGF logo
Octopus Ventures logo
Meltwind logo
M Ventures logo

NanoSyrinx is a synthetic biotech company developing a nano syringe delivery platform for intracellular delivery of biologic therapeutics.

Equity
$13.1M
09/10/2024
Article
F
Formo

Fermentation • Animal-free cheese

Woodline Partners logo
The Nature Conservancy logo
Seven Ventures logo
Sazaby League logo

Formo is a Berlin-based startup that produces animal-free cheese using micro fermentation of Koji proteins.

Series B
$61M
09/10/2024
Article
T
Thintronics

Electronic materials • High-performance insulators

Thintronics Inc. develops high-performance insulator materials for AI datacenters, networking, and RF/mmW applications to enhance electrical and mechanical properties.

Series A
Undisclosed
08/14/2024
Article
P
Polaris Electro-Optics

Integrated Photonics • Communications

Rhapsody Venture Partners logo
M Ventures logo
Buff Gold Ventures logo

Polaris Electro-Optics is a company specializing in the development of energy-efficient integrated photonics products for the communications and computation sectors, leveraging patented material and design innovations.

Seed
$3M
12/05/2023
Article
N
Nouscom

Clinical-stage immuno-oncology • Cancer immunotherapies

XGen Ventures logo
Versant Ventures logo
Revelation Partners logo
Panakès Partners logo

Nouscom is a clinical-stage immuno-oncology company specializing in off-the-shelf and personalized cancer immunotherapies using a proprietary viral vector platform.

Series C
$72.5M
11/14/2023
Article
C
CellFE

Life Sciences Tools • Cell Engineering

Riverine Ventures logo
M Ventures logo
Khosla Ventures logo
GreatPoint Ventures logo

CellFE is a life sciences tools company that has developed a microfluidics-based cell engineering platform, the Infinity MTx™ system, which streamlines the process of complex genetic cell editing, enabling efficient development and manufacturing of advanced cell therapies.

Series A
$22M
09/27/2023
Article
b
beeOLED

Deep-Tech • OLED Technology

TGFS logo
M Ventures logo
KBC logo
JBN-Invest logo

beeOLED is a deep-tech startup that develops deep-blue emitter technology for use in various device displays, integrating into existing OLED structures and manufacturing technology to improve power efficiency.

Series A
$14.4M
08/28/2023
Article